{
    "Wegovy": "Tue, 30 Sep 2025 13:49:00 +0200_Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 12, Status: Authorised",
    "Rybelsus": "Tue, 30 Sep 2025 13:39:00 +0200_Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 15, Status: Authorised",
    "Ozempic": "Tue, 30 Sep 2025 13:20:00 +0200_Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 18, Status: Authorised",
    "Kyinsu": "Fri, 19 Sep 2025 12:00:00 +0200_Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Status: Opinion",
    "Saxenda": "Thu, 31 Jul 2025 17:09:00 +0200_Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 19, Status: Authorised",
    "Mounjaro": "Fri, 12 Dec 2025 14:00:00 +0100_Summary of opinion: Mounjaro, 11/12/2025 Positive",
    "Qtern": "Thu, 18 Dec 2025 13:02:00 +0100_Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 14, Status: Authorised",
    "Xigduo": "Thu, 18 Dec 2025 13:01:00 +0100_Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised",
    "Ebymect": "Thu, 18 Dec 2025 13:00:00 +0100_Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised",
    "Xelevia": "Mon, 01 Dec 2025 17:33:00 +0100_Xelevia : EPAR - Procedural steps taken and scientific information after authorisation (archive)",
    "Velmetia": "Mon, 01 Dec 2025 16:44:00 +0100_Human medicines European public assessment report (EPAR): Velmetia, sitagliptin,metformin, Date of authorisation: 16/07/2008, Revision: 40, Status: Authorised",
    "Efficib": "Mon, 01 Dec 2025 14:10:00 +0100_Human medicines European public assessment report (EPAR): Efficib, sitagliptin,metformin, Date of authorisation: 15/07/2008, Revision: 37, Status: Authorised",
    "Tesavel": "Mon, 01 Dec 2025 12:08:00 +0100_Tesavel : EPAR - Procedural steps taken and scientific information after authorisation (archive)",
    "Steglujan": "Fri, 21 Nov 2025 15:58:00 +0100_Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin,sitagliptin, Date of authorisation: 23/03/2018, Revision: 14, Status: Authorised",
    "Ristfor": "Mon, 17 Nov 2025 17:00:00 +0100_Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Date of authorisation: 15/03/2010, Revision: 31, Status: Authorised",
    "Sitagliptin / Metformin hydrochloride Accord": "Thu, 13 Nov 2025 15:04:00 +0100_Sitagliptin / Metformin hydrochloride Accord : EPAR - Product information",
    "Janumet": "Thu, 13 Nov 2025 09:20:00 +0100_Human medicines European public assessment report (EPAR): Janumet, sitagliptin,metformin, Date of authorisation: 16/07/2008, Date of refusal: 18/02/2009, Revision: 34, Status: Authorised",
    "Sitagliptin SUN": "Mon, 10 Nov 2025 16:50:00 +0100_Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitagliptin fumarate, Date of authorisation: 09/12/2021, Revision: 3, Status: Authorised",
    "Januvia": "Fri, 31 Oct 2025 11:13:00 +0100_Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 35, Status: Authorised",
    "Ristaben": "Thu, 30 Oct 2025 16:36:00 +0100_Human medicines European public assessment report (EPAR): Ristaben, sitagliptin, Date of authorisation: 15/03/2010, Revision: 30, Status: Authorised",
    "Sitagliptin / Metformin hydrochloride Mylan": "Tue, 30 Sep 2025 15:27:00 +0200_Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised",
    "Apremilast Accord": "Wed, 07 Jan 2026 14:38:00 +0100_Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised",
    "Otezla": "Wed, 16 Jul 2025 10:53:00 +0200_Human medicines European public assessment report (EPAR): Otezla, apremilast, Date of authorisation: 15/01/2015, Revision: 24, Status: Authorised",
    "Invokana": "Thu, 18 Dec 2025 10:46:00 +0100_Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 27, Status: Authorised",
    "Synjardy": "Wed, 19 Nov 2025 12:50:00 +0100_Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 32, Status: Authorised",
    "Jentadueto": "Thu, 18 Dec 2025 15:15:00 +0100_Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 24, Status: Authorised",
    "Eucreas": "Mon, 08 Dec 2025 11:32:00 +0100_Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,metformin, Date of authorisation: 14/11/2007, Revision: 27, Status: Authorised",
    "Icandra (previously Vildagliptin / metformin hydrochloride Novartis)": "Fri, 05 Dec 2025 15:45:00 +0100_Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised",
    "Zomarist": "Fri, 05 Dec 2025 15:35:00 +0100_Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised",
    "Segluromet": "Fri, 21 Nov 2025 15:46:00 +0100_Human medicines European public assessment report (EPAR): Segluromet, ertugliflozin,metformin hydrochloride, Date of authorisation: 23/03/2018, Revision: 10, Status: Authorised",
    "Vildagliptin / Metformin hydrochloride Accord": "Fri, 25 Jul 2025 17:30:00 +0200_Human medicines European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord, vildagliptin,metformin hydrochloride, Date of authorisation: 24/03/2022, Revision: 4, Status: Authorised"
}